AB-BICA is primarily utilized in research settings, particularly in the study of cannabinoid receptors and their interactions. It serves as a selective agonist for the CB1 receptor, making it valuable for investigating the endocannabinoid system and its role in various physiological processes. Researchers employ AB-BICA to explore potential therapeutic applications, such as pain management, neuroprotection, and the treatment of conditions like anxiety or neurodegenerative disorders. Its specificity allows for precise studies on receptor behavior and signaling pathways, contributing to advancements in pharmacology and drug development.